ARCHIVES

In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

Sponsors Wanted: FDA Offers Incentives For Pediatric Oncology Drug Development.

March 10, 2000

ASPO Hears Proposals For Economic Attacks On Tobacco Industry

April 7, 1989

Acting NIH Director Says M.D. Anderson President John Mendelsohn Outlines 10-Point Plan For Cancer Research

February 20, 2009

Aranesp Improved Anemia In MDS In Phase II Trial

September 30, 2005

Cancer Advocacy: Jay Hedlund Resigns As NPCC President

May 14, 1999

Program Announcements. RAPID Program Date Change.

June 29, 2001